COMP <GO>
CSTL vs FLGT // FORWARD P/E MULTIPLE
Castle Biosciences Inc. (NASDAQ) VS. Fulgent Genetics Inc. (NASDAQ) • 15-METRIC TALLY: CSTL 8
— FLGT 2
■ METRIC PARITY
LAST: $38.51 (+4.99%) • MKT CAP: $1.18B
forward-pe
—
LAST: $21.68 (+0.74%) • MKT CAP: $596.5M
forward-pe
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CSTL VS. FLGT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CSTL | FLGT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 79.40% | 40.60% | +38.80 | CSTL | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -9.30% | -6.80% | -2.50 | FLGT | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.41% | -20.82% | +23.23 | CSTL | /fcf-yield <GO> |
| Operating Margin | -12.40% | -28.20% | +15.80 | CSTL | /operating-margins <GO> |
| Net Profit Margin | -7.00% | -18.80% | +11.80 | CSTL | /net-margins <GO> |
| Revenue Growth (YoY) | 3.70% | 13.80% | -10.10 | FLGT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.97 | 4.44 | +2.53 | CSTL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 3/9 | +3.00 | CSTL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.6 | 56.3 | +8.30 | CSTL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.18B | $596.5M | $579.9M | CSTL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CSTL REV | FLGT REV | CSTL GROSS % | FLGT GROSS % | CSTL FCF | FLGT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $344.2M | $322.7M | 79.4% | 40.6% | $28.3M | -$124.2M |
| FY 2024 | $332.1M | $283.5M | 81.9% | 37.8% | $36.5M | -$19.3M |
| FY 2023 | $219.8M | $289.2M | — | — | -$5.6M | $27.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CSTL // BETA —
FLGT // BETA —